Compare Bio Protocol (BIO) vs Morpho (MORPHO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Morpho — how do they compare? Bio Protocol trades at Rp440.25 (market cap Rp1,01T, Rp179,48M 24h volume), while Morpho trades at Rp34,807 (market cap Rp18,06T, Rp186,44M 24h volume). The key difference: Morpho is far larger — about 17.9× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 516,6M / 1B MORPHO (52%) for Morpho. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and Morpho for 16 Days on average.
| BIO | MORPHO | |
|---|---|---|
Market Cap | Rp1,01T | Rp18,06T |
Volume (24h) | Rp179,48M | Rp186,44M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 516,6M / 1B MORPHO (52%) |
Typical Hold Time | 17 Days | 16 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Morpho shows bullish technical momentum with a current price of Rp35,260, trading near resistance levels. The asset maintains strong moving average signals while oscillators remain neutral. With 52% of the max supply in circulation and an average hold time of 16 days, the token demonstrates moderate distribution and holding patterns. No major protocol updates or ecosystem developments were reported recently.
Overall outlook is cautiously optimistic with technical strength but limited fundamental catalysts. Key opportunities include potential breakout above resistance levels, while risks involve low liquidity and the absence of recent ecosystem developments. Investors should monitor for protocol updates and increased trading volume.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Morpho
Morpho is an open, efficient, and trustless platform designed for earning yield and borrowing assets. Lenders utilize Morpho Vaults to maximize their returns, while borrowers gain access to assets through Morpho Markets. Its permissionless infrastructure empowers developers and businesses to create markets, curate vaults, and build applications. With immutable contracts, isolated lending markets, improved interest rates, and low gas fees, Morpho offers efficiency, flexibility, and a developer-friendly environment.
Read more on MORPHO →
